Verastem Historical Balance Sheet

VSTM Stock

USD 6.65 0.17 2.49%

Trend analysis of Verastem balance sheet accounts such as Total Assets of 125.4 M, Other Current Liab of 20.5 M, Total Current Liabilities of 16.6 M or Total Stockholder Equity of 75.3 M provides information on Verastem's total assets, liabilities, and equity, which is the actual value of Verastem to its prevalent stockholders. By breaking down trends over time using Verastem balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Verastem latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Verastem is a good buy for the upcoming year.

Verastem Inventory

(86.16 Million)

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verastem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.

About Verastem Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Verastem at a specified time, usually calculated after every quarter, six months, or one year. Verastem Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Verastem and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Verastem currently owns. An asset can also be divided into two categories, current and non-current.

Verastem Balance Sheet Chart

At this time, Verastem's Common Stock Total Equity is very stable compared to the past year. As of the 22nd of March 2025, Other Stockholder Equity is likely to grow to about 1 B, while Total Current Liabilities is likely to drop about 16.6 M.

Total Assets Other Current Liab Total Current Liabilities Accounts Payable

Add Fundamental

Total Assets

Total assets refers to the total amount of Verastem assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Verastem books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Verastem balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Verastem are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents Verastem obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Verastem are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most accounts from Verastem's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Verastem current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verastem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.At this time, Verastem's Common Stock Total Equity is very stable compared to the past year. As of the 22nd of March 2025, Other Stockholder Equity is likely to grow to about 1 B, while Total Current Liabilities is likely to drop about 16.6 M.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	15.0M	17.0M	19.5M	20.5M
Total Assets	95.1M	149.7M	172.2M	125.4M

Other Current Liab Total Assets

Verastem balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Accounts Payable	Cash	Common Stock Shares Outstanding	Other Current Assets	Total Liab	Common Stock	Property Plant Equipment	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Other Stockholder Equity	Property Plant And Equipment Gross	Total Current Assets	Net Tangible Assets
Total Assets		0.66	0.82	0.56	0.66	0.68	0.35	0.48	0.7	0.18	0.19	0.55	0.26	0.16	-0.46	0.23	0.16	0.15	0.92	0.36	0.71	0.4	0.52	0.19	0.93	-0.04
Other Current Liab	0.66		0.7	0.44	0.42	0.74	0.8	0.79	0.51	0.38	-0.14	0.6	-0.03	-0.29	-0.79	-0.41	-0.22	-0.3	0.79	0.82	0.47	0.1	0.86	0.32	0.79	-0.04
Total Current Liabilities	0.82	0.7		0.17	0.85	0.73	0.55	0.66	0.8	0.35	-0.1	0.74	0.33	0.19	-0.75	0.17	0.42	0.33	0.76	0.58	0.32	0.53	0.73	0.54	0.79	-0.5
Total Stockholder Equity	0.56	0.44	0.17		0.01	0.43	0.06	0.12	-0.14	0.2	0.46	-0.03	0.0	-0.37	-0.09	-0.16	-0.43	-0.35	0.6	0.13	0.76	-0.43	0.23	-0.14	0.58	0.56
Accounts Payable	0.66	0.42	0.85	0.01		0.57	0.28	0.33	0.76	-0.03	-0.13	0.39	0.27	0.29	-0.45	0.25	0.47	0.35	0.56	0.25	0.07	0.52	0.45	0.35	0.58	-0.61
Cash	0.68	0.74	0.73	0.43	0.57		0.44	0.49	0.44	0.42	0.06	0.6	0.06	-0.47	-0.59	-0.29	-0.06	-0.11	0.76	0.51	0.49	0.15	0.62	0.39	0.76	-0.05
Common Stock Shares Outstanding	0.35	0.8	0.55	0.06	0.28	0.44		0.94	0.5	0.29	-0.39	0.52	0.07	-0.13	-0.91	-0.29	0.07	-0.08	0.39	0.97	0.14	0.07	0.93	0.5	0.42	-0.38
Other Current Assets	0.48	0.79	0.66	0.12	0.33	0.49	0.94		0.57	0.45	-0.22	0.63	0.25	-0.03	-0.94	-0.12	0.2	0.13	0.48	0.96	0.2	0.19	0.95	0.47	0.51	-0.36
Total Liab	0.7	0.51	0.8	-0.14	0.76	0.44	0.5	0.57		0.01	-0.22	0.63	0.32	0.48	-0.54	0.36	0.53	0.42	0.59	0.44	0.21	0.8	0.54	0.34	0.61	-0.52
Common Stock	0.18	0.38	0.35	0.2	-0.03	0.42	0.29	0.45	0.01		0.09	0.47	0.21	-0.27	-0.55	-0.12	0.03	0.16	0.17	0.51	0.04	-0.1	0.47	0.41	0.19	-0.05
Property Plant Equipment	0.19	-0.14	-0.1	0.46	-0.13	0.06	-0.39	-0.22	-0.22	0.09		0.04	0.57	-0.1	0.27	-0.02	-0.11	0.13	0.17	-0.32	0.3	-0.22	-0.22	-0.26	0.16	0.41
Other Liab	0.55	0.6	0.74	-0.03	0.39	0.6	0.52	0.63	0.63	0.47	0.04		0.39	0.06	-0.66	-0.03	0.27	0.25	0.59	0.57	0.32	0.55	0.6	0.59	0.62	-0.3
Property Plant And Equipment Net	0.26	-0.03	0.33	0.0	0.27	0.06	0.07	0.25	0.32	0.21	0.57	0.39		0.39	-0.24	0.36	0.6	0.71	0.1	0.12	-0.01	0.23	0.24	0.3	0.13	-0.39
Net Debt	0.16	-0.29	0.19	-0.37	0.29	-0.47	-0.13	-0.03	0.48	-0.27	-0.1	0.06	0.39		0.1	0.81	0.67	0.66	-0.06	-0.2	-0.17	0.63	-0.15	-0.01	-0.04	-0.46
Retained Earnings	-0.46	-0.79	-0.75	-0.09	-0.45	-0.59	-0.91	-0.94	-0.54	-0.55	0.27	-0.66	-0.24	0.1		0.17	-0.24	-0.15	-0.45	-0.95	-0.11	-0.14	-0.97	-0.64	-0.48	0.5
Non Current Assets Total	0.23	-0.41	0.17	-0.16	0.25	-0.29	-0.29	-0.12	0.36	-0.12	-0.02	-0.03	0.36	0.81	0.17		0.74	0.76	-0.07	-0.29	0.01	0.5	-0.22	0.05	-0.05	-0.35
Non Currrent Assets Other	0.16	-0.22	0.42	-0.43	0.47	-0.06	0.07	0.2	0.53	0.03	-0.11	0.27	0.6	0.67	-0.24	0.74		0.94	-0.11	0.06	-0.18	0.55	0.17	0.5	-0.07	-0.77
Other Assets	0.15	-0.3	0.33	-0.35	0.35	-0.11	-0.08	0.13	0.42	0.16	0.13	0.25	0.71	0.66	-0.15	0.76	0.94		-0.12	-0.04	-0.18	0.5	0.06	0.32	-0.09	-0.61
Cash And Short Term Investments	0.92	0.79	0.76	0.6	0.56	0.76	0.39	0.48	0.59	0.17	0.17	0.59	0.1	-0.06	-0.45	-0.07	-0.11	-0.12		0.39	0.75	0.35	0.52	0.09	1.0	0.14
Common Stock Total Equity	0.36	0.82	0.58	0.13	0.25	0.51	0.97	0.96	0.44	0.51	-0.32	0.57	0.12	-0.2	-0.95	-0.29	0.06	-0.04	0.39		0.14	0.02	0.96	0.55	0.42	-0.35
Short Term Investments	0.71	0.47	0.32	0.76	0.07	0.49	0.14	0.2	0.21	0.04	0.3	0.32	-0.01	-0.17	-0.11	0.01	-0.18	-0.18	0.75	0.14		0.04	0.23	0.01	0.74	0.49
Non Current Liabilities Total	0.4	0.1	0.53	-0.43	0.52	0.15	0.07	0.19	0.8	-0.1	-0.22	0.55	0.23	0.63	-0.14	0.5	0.55	0.5	0.35	0.02	0.04		0.07	0.1	0.36	-0.4
Other Stockholder Equity	0.52	0.86	0.73	0.23	0.45	0.62	0.93	0.95	0.54	0.47	-0.22	0.6	0.24	-0.15	-0.97	-0.22	0.17	0.06	0.52	0.96	0.23	0.07		0.59	0.55	-0.42
Property Plant And Equipment Gross	0.19	0.32	0.54	-0.14	0.35	0.39	0.5	0.47	0.34	0.41	-0.26	0.59	0.3	-0.01	-0.64	0.05	0.5	0.32	0.09	0.55	0.01	0.1	0.59		0.13	-0.64
Total Current Assets	0.93	0.79	0.79	0.58	0.58	0.76	0.42	0.51	0.61	0.19	0.16	0.62	0.13	-0.04	-0.48	-0.05	-0.07	-0.09	1.0	0.42	0.74	0.36	0.55	0.13		0.09
Net Tangible Assets	-0.04	-0.04	-0.5	0.56	-0.61	-0.05	-0.38	-0.36	-0.52	-0.05	0.41	-0.3	-0.39	-0.46	0.5	-0.35	-0.77	-0.61	0.14	-0.35	0.49	-0.4	-0.42	-0.64	0.09

Click cells to compare fundamentals

Verastem Account Relationship Matchups

Verastem balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	154.3M	108.7M	95.1M	149.7M	172.2M	125.4M
Other Current Liab	14.1M	15.0M	15.0M	17.0M	19.5M	20.5M
Total Current Liabilities	17.1M	18.6M	21.7M	26.4M	30.3M	16.6M
Total Stockholder Equity	115.3M	87.6M	47.4M	57.4M	66.0M	75.3M
Accounts Payable	1.9M	2.3M	4.9M	7.2M	8.3M	5.0M
Cash	67.8M	100.3M	74.9M	78.8M	90.7M	63.4M
Common Stock Shares Outstanding	12.8M	14.5M	16.1M	22.1M	25.4M	26.6M
Other Current Assets	6.9M	5.0M	4.9M	6.6M	7.5M	7.9M
Total Liab	39.1M	21.1M	47.7M	92.3M	106.2M	111.5M
Common Stock	8K	17K	19K	20K	3.5K	3.3K
Property Plant Equipment	947K	3.1M	210K	92K	105.8K	100.5K
Property Plant And Equipment Net	3.1M	210K	1.9M	1.2M	1.4M	1.8M
Net Debt	(45.2M)	(98.0M)	(47.9M)	(36.4M)	(32.7M)	(34.4M)
Retained Earnings	(592.5M)	(663.7M)	(737.5M)	(824.9M)	(742.4M)	(705.3M)
Non Current Assets Total	9.4M	2.9M	2.2M	6.0M	5.4M	5.2M
Non Currrent Assets Other	274K	2.5M	58K	4.6M	5.3M	4.2M
Other Assets	36.1M	9.0M	410K	299K	343.9K	326.7K
Cash And Short Term Investments	141.2M	100.3M	87.9M	137.1M	157.7M	115.7M
Common Stock Total Equity	8K	17K	19K	20K	23K	24.2K
Short Term Investments	73.4M	79.0M	13.0M	59.2M	68.1M	61.7M
Liabilities And Stockholders Equity	154.3M	108.7M	95.1M	149.7M	172.2M	134.7M
Non Current Liabilities Total	22.0M	2.5M	26.0M	44.8M	51.5M	34.2M
Other Stockholder Equity	707.7M	751.2M	784.9M	861.1M	990.3M	1.0B
Property Plant And Equipment Gross	416K	4.2M	3.4M	2.8M	3.2M	2.2M
Total Current Assets	144.9M	105.7M	92.9M	143.7M	165.2M	119.1M
Accumulated Other Comprehensive Income	14K	53K	34K	13K	15.0K	15.7K
Net Tangible Assets	(12.8M)	115.3M	87.6M	47.4M	42.7M	63.3M
Long Term Debt	19.1M	249K	24.5M	40.1M	46.1M	29.1M
Net Receivables	239K	516K	31K	42K	37.8K	35.9K
Retained Earnings Total Equity	(524.8M)	(592.5M)	(663.7M)	(737.5M)	(663.8M)	(630.6M)
Capital Surpluse	531.9M	707.7M	751.2M	784.9M	902.6M	481.7M
Non Current Liabilities Other	4.4M	2.9M	2.3M	1.5M	1.7M	1.4M
Short Long Term Debt Total	22.5M	2.3M	27.1M	41.6M	37.4M	38.4M
Long Term Debt Total	103.6M	19.1M	249K	24.5M	22.1M	36.9M
Net Invested Capital	134.3M	87.8M	72.2M	97.5M	87.7M	93.7M
Net Working Capital	127.8M	87.2M	71.2M	117.3M	105.6M	85.2M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Verastem is a strong investment it is important to analyze Verastem's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Verastem's future performance. For an informed investment choice regarding Verastem Stock, refer to the following important reports:

How To Invest In Verastem

Details

Is Verastem Stock a good investment?

Details

What is Verastem's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.

You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verastem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.14)

Revenue Per Share

0.331

Quarterly Revenue Growth

(1.00)

Return On Assets

(0.47)

Return On Equity

(1.37)

The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Verastem Historical Balance Sheet

Verastem Inventory

(86.16 Million)

About Verastem Balance Sheet Analysis

Verastem Balance Sheet Chart

Total Assets

Total Current Liabilities

Accounts Payable

Verastem balance sheet Correlations

Verastem Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Verastem balance sheet Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock Total Equity	+ 0.97	Common Stock Shares Outstanding
Common Stock Total Equity	+ 0.96	Other Current Assets
Other Stockholder Equity	+ 0.96	Common Stock Total Equity
Other Stockholder Equity	+ 0.95	Other Current Assets
Other Current Assets	+ 0.94	Common Stock Shares Outstanding

Other Stockholder Equity	- 0.97	Retained Earnings
Common Stock Total Equity	- 0.95	Retained Earnings
Retained Earnings	- 0.94	Other Current Assets
Retained Earnings	- 0.91	Common Stock Shares Outstanding
Retained Earnings	- 0.79	Other Current Liab
Net Tangible Assets	- 0.77	Non Currrent Assets Other